{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:08:42Z","timestamp":1774426122753,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.tripleo.2007.01.008","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T13:34:09Z","timestamp":1178631249000},"page":"473-477","source":"Crossref","is-referenced-by-count":82,"title":["Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management"],"prefix":"10.1016","volume":"104","author":[{"given":"Lucio","family":"Montebugnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Felicetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide Bartolomeo","family":"Gissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Pizzigallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Andrea","family":"Pelliccioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2007.01.008_bib1","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1200\/JCO.2005.02.9579","article-title":"Bisphosphonates for treatment and prevention of bone metastases","volume":"23","author":"Michaelson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2000.18.1.72","article-title":"Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib3","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology Bisphosphonates Expert Panel","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib4","first-page":"462","article-title":"The use of bisphosphonates in the treatment of osteoporosis","volume":"17","author":"Delmas","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: Bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2007.01.008_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive care in cancer","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.tripleo.2007.01.008_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1601-0825.2005.01130.x","article-title":"Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy","volume":"11","author":"Pires","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2007.01.008_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","article-title":"Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates","volume":"116","author":"Farrugia","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.tripleo.2007.01.008_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.joms.2003.11.009","article-title":"New foundations in understanding osteonecrosis of the jaws","volume":"62","author":"Assael","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.tripleo.2007.01.008_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib18","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2007.01.008_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2007.01.008_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","article-title":"A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders","volume":"17","author":"Murakami","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2007.01.008_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","volume":"30","author":"Van Beek","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2007.01.008_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1993.11.3.491","article-title":"Palliative pamidronate treatment in patients with bone metastases from breast cancer","volume":"11","author":"van Holten-Verzantvoort","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2007.01.008_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/annonc\/mdg194","article-title":"Bisphosphonates: new antiangiogenic molecules in cancer treatment?","volume":"14","author":"Vincenzi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2007.01.008_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.tripleo.2007.01.008_bib26","first-page":"88","article-title":"Mechanisms of action in bisphosphonates","volume":"15","author":"Hoshino","year":"2005","journal-title":"Clin Calcium"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210407000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210407000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T19:35:22Z","timestamp":1556393722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210407000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1079210407000261"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2007.01.008","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}